TY - JOUR
T1 - Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology
T2 - A North-American survey
AU - Walbert, Tobias
AU - Glantz, Michael
AU - Schultz, Lonni
AU - Puduvalli, Vinay K.
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2015.
PY - 2016/1
Y1 - 2016/1
N2 - Specialized palliative care (PC) services have emerged to address symptoms and provide end-of-life management for patients with brain tumors. The utilization patterns of PC in neuro-oncology are unknown. A 22-question survey was distributed to participants of the society for neuro-oncology annual meeting 2012 (n = 4487). Nonparametric methods including Wilcoxon two-sample and Kruskal-Wallis tests were used to assess differences in responses. 239 (5.3 %) evaluable responses were received; 79 % of respondents were physicians, and 17 % were nurses or midlevel providers. Forty-seven percent were medical or neuro-oncologists, 31 % neurosurgeons and 11 % radiation oncologists. Forty percent had no formal training in PC, 57 % had some formal training and 3 % completed a PC fellowship. Seventy-nine percent practiced in an academic setting. Of the respondents, 57 % referred patients to PC when symptoms required treatment and 18 % at end of life. Only 51 % of all providers felt comfortable dealing with end-of-life issues and symptoms, while 33 % did not. Fifty-one percent preferred a service named “Supportive Care” rather than “Palliative Care” (MDs>midlevel providers, p<0.001), and 32 % felt that patient expectations for ongoing therapy hindered their ability to make PC referrals. Female gender, formal training in neuro-oncology and PC, and medical versus surgical neuro-oncology training were significantly associated with hospice referral, comfort in dealing with end-of-life issues, and ease of access to PC services. Provider level, specialty, gender, training in PC and neuro-oncology have significant impact on the utilization of PC and hospice in neurooncology.
AB - Specialized palliative care (PC) services have emerged to address symptoms and provide end-of-life management for patients with brain tumors. The utilization patterns of PC in neuro-oncology are unknown. A 22-question survey was distributed to participants of the society for neuro-oncology annual meeting 2012 (n = 4487). Nonparametric methods including Wilcoxon two-sample and Kruskal-Wallis tests were used to assess differences in responses. 239 (5.3 %) evaluable responses were received; 79 % of respondents were physicians, and 17 % were nurses or midlevel providers. Forty-seven percent were medical or neuro-oncologists, 31 % neurosurgeons and 11 % radiation oncologists. Forty percent had no formal training in PC, 57 % had some formal training and 3 % completed a PC fellowship. Seventy-nine percent practiced in an academic setting. Of the respondents, 57 % referred patients to PC when symptoms required treatment and 18 % at end of life. Only 51 % of all providers felt comfortable dealing with end-of-life issues and symptoms, while 33 % did not. Fifty-one percent preferred a service named “Supportive Care” rather than “Palliative Care” (MDs>midlevel providers, p<0.001), and 32 % felt that patient expectations for ongoing therapy hindered their ability to make PC referrals. Female gender, formal training in neuro-oncology and PC, and medical versus surgical neuro-oncology training were significantly associated with hospice referral, comfort in dealing with end-of-life issues, and ease of access to PC services. Provider level, specialty, gender, training in PC and neuro-oncology have significant impact on the utilization of PC and hospice in neurooncology.
UR - http://www.scopus.com/inward/record.url?scp=84945587923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84945587923&partnerID=8YFLogxK
U2 - 10.1007/s11060-015-1973-0
DO - 10.1007/s11060-015-1973-0
M3 - Article
C2 - 26518539
AN - SCOPUS:84945587923
SN - 0167-594X
VL - 126
SP - 337
EP - 345
JO - Journal of neuro-oncology
JF - Journal of neuro-oncology
IS - 2
ER -